US Patent Issued to SHENZHEN YHLO BIOTECH on May 20 for "Leptin immunogens, hybridoma cells, monoclonal antibodies, polyclonal antibodies and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,937, issued on May 20, was assigned to SHENZHEN YHLO BIOTECH Co. LTD (Shenzhen, China).

"Leptin immunogens, hybridoma cells, monoclonal antibodies, polyclonal antibodies and use thereof" was invented by Mi Zhou (Shenzhen, China), Yujian Lin (Shenzhen, China), Chungen Qian (Shenzhen, China) and Kunhui Hu (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a leptin immunogen, hybridoma cells, a monoclonal antibody, a polyclonal antibody and use thereof. The leptin immunogen includes a polypeptide having an amino acid sequence as shown in SEQ ID NO: 1. The anti-leptin monoclonal antibody prepared with the leptin immunogen has g...